Dr. Reddy’s Laboratories has announced the sale of its wholly owned subsidiary, Svaas Wellness Limited, for a total consideration of ₹2.23 crore. The agreement for the sale was finalised on April 7, 2026, and the transaction was completed on the same day.
Svaas Wellness Limited, which contributed ₹28.5 crore to Dr. Reddy’s Laboratories’ consolidated turnover in the fiscal year 2025, representing approximately 0.09% of the total turnover, will cease to be a subsidiary following this transaction.
The buyer, Enspirit Technology Services Private Limited, is based in Hyderabad, Telangana, and does not belong to the promoter or promoter group of Dr. Reddy’s Laboratories. Additionally, the transaction does not qualify as a related party transaction, ensuring it was conducted at arm’s length.
This divestment aligns with Dr. Reddy’s Laboratories’ strategic business decisions, though further details on the rationale behind the sale were not disclosed in the filing.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).